MAIA

USD

MAIA Biotechnology Inc. Common Stock

$1.130-0.030 (-2.586%)

Цена в режиме реального времени

Healthcare

Биотехнология

Соединенные Штаты

График цен

Loading Chart...

Ключевые показатели

Рыночные показатели

Фундаментальные показатели компании

Статистические данные торговли

Рыночные показатели

Открытие

$1.160

Максимум

$1.160

Минимум

$1.125

Объем

0.12M

Фундаментальные показатели компании

Рыночная капитализация

37.3M

Отрасль

Биотехнология

Страна

United States

Статистические данные торговли

Средний объем

0.58M

Биржа

ASE

Валюта

USD

52-недельный диапазон

Минимум $1.12Текущая $1.130Максимум $3.48

Связанные новости

27 окт. 2025 г. · 14:45

GlobeNewswire

MAIA Biotechnology Presents Trial in Progress Poster at the 2025 AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics

First five patients in Part C (expansion) of THIO-101 Phase 2 clinical trial enrolled in Taiwan and Turkey CHICAGO, Oct. 27, 2025 (GLOBE NEWSWIRE) -- MAIA Biotechnology, Inc. (NYSE:MAIA) ("MAIA", the "Company"), a

Просмотреть больше

MAIA Biotechnology Presents Trial in Progress Poster at the 2025 AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics

23 окт. 2025 г. · 12:36

GlobeNewswire

MAIA Biotechnology Details 30-Month Patient Survival in Ongoing Phase 2 Clinical Trial in Non-Small Cell Lung Cancer

Outstanding measure of efficacy relative to high-risk cancers with limited treatment options CHICAGO, Oct. 23, 2025 (GLOBE NEWSWIRE) -- MAIA Biotechnology, Inc. (NYSE:MAIA) ("MAIA", the "Company"), a clinical-stage

Просмотреть больше

MAIA Biotechnology Details 30-Month Patient Survival in Ongoing Phase 2 Clinical Trial in Non-Small Cell Lung Cancer

13 окт. 2025 г. · 20:20

GlobeNewswire

MAIA Biotechnology Announces $736,600 Private Placement

CHICAGO, IL, Oct. 13, 2025 (GLOBE NEWSWIRE) -- MAIA Biotechnology, Inc., (NYSE:MAIA) ("MAIA", the "Company"), a clinical-stage biopharmaceutical company developing targeted immunotherapies for cancer, today announced

Просмотреть больше

MAIA Biotechnology Announces $736,600 Private Placement

7 окт. 2025 г. · 13:00

PR Newswire

Clinical Breakthroughs Converge as Immunotherapy Market Surges Past $136 Billion

USA News Group News Commentary – Major pharmaceutical companies are unveiling breakthrough cancer data at the European Society for Medical Oncology...

Просмотреть больше

Clinical Breakthroughs Converge as Immunotherapy Market Surges Past $136 Billion

7 окт. 2025 г. · 12:47

GlobeNewswire

MAIA Biotechnology to Initiate Digital Asset Treasury Strategy Focused on Top-Tier Crypto Assets

MAIA's Board of Directors authorizes holdings of up to 90% of the Company's liquid assets in cryptocurrencies (BTC), Ethereum (ETH), and USD Coin (USDC) CHICAGO, Oct. 07, 2025 (GLOBE NEWSWIRE) -- MAIA Biotechnology,

Просмотреть больше